Belgium – Pharmaceutical products – SPÉCIALITÉS PHARMACEUTIQUES À BASE D'AMOXICILLINE/ACIDE CLAVULANIQUE 2G/200MG, 1G/20
Association iris-Achats awarded €547K to EUROGENERICS for Healthcare & Medical in April 2025 — one of 165 awards this buyer has made, above its typical award size.
Buying agency
Association iris-AchatsWinning supplier
EUROGENERICSContract description
Belgium – Pharmaceutical products – SPÉCIALITÉS PHARMACEUTIQUES À BASE D'AMOXICILLINE/ACIDE CLAVULANIQUE 2G/200MG, 1G/200MG ET 500MG/50MG (VOIE INTRAVEINEUSE)
Related awards · Association iris-Achats
165 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-667667-2024Klinerva B.V.(Eurocept Homecare)€6.4M04 Nov 2024 Professional Services
- ocds-ted-693732-2025-6Bracco€3.5M21 Oct 2025 Professional Services
- ocds-ted-219951-2026SOCIETE BELGE D'INFORMATIQUE MEDICALE€3.5M31 Mar 2026 IT
Other wins · EUROGENERICS
12 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-240772-2025-1Universiteit Gent€588K14 Apr 2025 Healthcare
- ocds-ted-384328-2026VZW VITAZ€560K04 Jun 2026 Healthcare
- ocds-ted-679245-2025VZW VITAZ€400K15 Oct 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Association iris-Achats and EUROGENERICS — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back